GSK to purchase meals allergy drug maker RAPT in $2.2bn deal | GSK
GSK, the UK’s second-biggest drugmaker, has unveiled a $2.2bn (£1.6bn) deal to amass a Californian biotech firm which is creating ...
GSK, the UK’s second-biggest drugmaker, has unveiled a $2.2bn (£1.6bn) deal to amass a Californian biotech firm which is creating ...
Copyright © 2025 Greater USA.
Greater USA is not responsible for the content of external sites.